Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.

Replacing Animal Testing with Stem Cell-Organoids : Advantages and Limitations

Open access
Park, Guiyoung, Rim, Yeri Alice, Sohn, Yeowon, Nam, Yoojun, Ju, Ji Hyeon · 2024 · Stem Cell Reviews and Reports

Abstract

Various groups including animal protection organizations, medical organizations, research centers, and even federal agencies such as the U.S. Food and Drug Administration, are working to minimize animal use in scientific experiments. This movement primarily stems from animal welfare and ethical concerns. However, recent advances in technology and new studies in medicine have contributed to an increase in animal experiments throughout the years. With the rapid increase in animal testing, concerns arise including ethical issues, high cost, complex procedures, and potential inaccuracies. Alternative solutions have recently been investigated to address the problems of animal testing. Some of these technologies are related to stem cell technologies, such as organ-on-a-chip, organoids, and induced pluripotent stem cell models. The aim of the review is to focus on stem cell related methodologies, such as organoids, that can serve as an alternative to animal testing and discuss its advantages and limitations, alongside regulatory considerations. Although stem cell related methodologies has shortcomings, it has potential to replace animal testing. Achieving this requires further research on stem cells, with potential societal and technological benefits. Graphical Abstract

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s12015-024-10723-5

Cites

90 of 90 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 (A) Procedure of new drug approval as stated by the Food and Drug Administration (FDA). In the preclinical research stage, small, medium, and large animals are usually used for testing new drugs. (B) iPSCs that can replacing animal testing. PBMCs or fibroblasts are reprogrammed to iPSCs and subsequently differentiated into target modeling cells such as neurons, cardiomyocytes, and hepatocytes. (C) iPSC-derived 3D organoids enable in vitro efficacy and safety testing. Organ-on-a-chip embedded with organoids used in in vitro tests, created using BioRender
Fig. 1 (A) Procedure of new drug approval as stated by the Food and Drug Administration (FDA). In the preclinical research stage, small, medium, and large animals are usually used for testing new drugs. (B) iPSCs that can replacing animal testing. PBMCs or fibroblasts are reprogrammed to iPSCs and subsequently differentiated into target modeling cells such as neurons, cardiomyocytes, and hepatocytes. (C) iPSC-derived 3D organoids enable in vitro efficacy and safety testing. Organ-on-a-chip embedded with organoids used in in vitro tests, created using BioRenderCC BY · PubMed Central
Fig. 2 A BioRender diagram depicts diverse stem cell technologies for human organs
Fig. 2 A BioRender diagram depicts diverse stem cell technologies for human organsCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 90 references

Research works printed but not linked: 2

  1. Center for Drug Evaluation and, R., R. Center for Biologics Evaluation and, and H. International Conference on, Guidance for industry: S6 preclinical safety evaluation of biotechnology-derived pharmaceuticals (1997). Rockville, MD: U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research: Center for Biologics Evaluation and Research.
  2. Administration, U. S. F. D. (2021). Advancing New Alternative Methodologies at FDA. Jan U.S. Food & Drug Administration: FDA website. pp. 1–34.

Cited by

See all 92

Metadata

Authors
Park, G., Rim, Y. A., Sohn, Y., Nam, Y., & Ju, J. H.
Affiliations
  • Sungshin Women's University (KR)
  • The Catholic University of Korea Seoul St. Mary's Hospital (KR)
  • Sungkyunkwan University (KR)
Corresponding author
  • Nam, Yoojun
  • Ju, Ji Hyeon
Venue
Stem Cell Reviews and Reports
Published
2024-04-19
Volume
20
Issue
6
Pages
1375-1386
ISSN
  • 1550-8943 (ISSN-L)
  • 2629-3269
  • 2629-3277
OpenAlex
W4394955524
Cited by
92
References
90
Citations by year
2026: 41 · 2025: 41 · 2024: 10
FWCI
6.93
Type
journal article
Language
en
Open access
Licence
Locations
  • Stem Cell Reviews and Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Korea Health Industry Development Institute (HI22C1314)
Topics
  • Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Health Sciences › Nursing › Issues, ethics and legal aspects › Biomedical Ethics and Regulation
Keywords
alternatives to animal testing, organoids, organ-on-a-chip, induced pluripotent stem cells, 3D cell culture models, animal welfare, animal research ethics, regulatory considerations
MeSH terms
Animals, Animal Testing Alternatives, Humans, Organoids, Stem Cells, Induced Pluripotent Stem Cells, Stem Cell Research

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Replacing Animal Testing with Stem Cell-Organoids : Advantages and Limitations. https://app.cochat.ai/papers/10.1007/s12015-024-10723-5
The paper
Park, G., Rim, Y. A., Sohn, Y., Nam, Y., & Ju, J. H. (2024). Replacing Animal Testing with Stem Cell-Organoids : Advantages and Limitations. Stem Cell Reviews and Reports. https://doi.org/10.1007/s12015-024-10723-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.